Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Aziyo Biologics
Aziyo develops customized tissue products to restore health and mobility to patients.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cerapedics
CeraPedics is a medical device company that develops and commercializes osteobiologic products.
Sector
Subsector
Keywords
Location
total rounds
total raised
Isto Biologics
Isto Biologics is developing evidence-based solutions for bone regeneration and cell therapy.
Sector
Subsector
Location
NTL Biologica
NTL Biologica is a medical technology company that develops stem-cell therapy for repairing torn meniscal cartilage.
Sector
Subsector
Keywords
Location
M&A Details1
Transaction name
Acquired by
Ferring Pharmaceuticals
announced date
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 06.01.2014. Their latest investor The New Markets Growth Fund. Their latest round Debt Financing
Saints Capital
Saints Capital acquires illiquid assets, providing cash exit for existing investors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
PTV Healthcare Capital
PTV Healthcare Capital is a late-stage venture and expansion capital firm based in Austin, Texas.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
EDF Ventures
EDF Ventures is a venture capital firm that partners with innovative startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
MB Venture Partners
MB Venture Partners is a Tennessee-based venture capital firm that invests in life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
The Vertical Group
The Vertical Group is a venture capital firm focused on medical technology and biotechnology.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Heron Capital
Heron Capital is a venture capital fund that invests in mid and growth stage companies focused on life sciences.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Westfield Capital Management
Westfield Capital Management is an SEC-registered investment advisor.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
The New Markets Growth Fund
New Markets Growth Fund is a 2003 SBA development growth fund managed by Robb Doub, Mark Grovic, and Don Spero.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors9
Number of lead investors
Number of investors
The New Markets Growth Fund
New Markets Growth Fund is a 2003 SBA development growth fund managed by Robb Doub, Mark Grovic, and Don Spero.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
EDF Ventures
EDF Ventures is a venture capital firm that partners with innovative startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Maryland Venture Fund
Maryland Venture Fund is an evergreen venture capital fund focused on funding and growing exceptional businesses in Maryland.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Tom Roueche
Mr. Roueche has over 25 years experience in early and growth stage companies in the medical device industry. Most recently he has leveraged core competencies in market development, operations, regulatory affairs, and product knowledge to provide business strategy advice to early and mid-stage medical technology companies. In 2016, Mr. Roueche led the sale of BioSET, a premier tissue regeneration technology company, to Ferring Pharmaceuticals. Prior to co-founding BioSET in 2001, he spent 4 years leading the new market business units in arthroscopy and interventional cardiology for InnerDyne, Inc, until the company’s acquisition by U.S. Surgical, a Tyco Healthcare company in 2000. Previously, Mr. Roueche spent 7 years with sports medicine medical device manufacturer Orthopedic Technology, Inc., where he held increasing roles of responsibility, culminating in the senior Sales and Marketing position. Mr. Roueche aided in that company’s successful IPO in 1995 and eventual sale to DePuy, Inc., a Johnson and Johnson Company in 1997. Mr. Roueche studied Finance and Business Administration at the University of Oklahoma
organization founded
Tom Roueche
Paul Zamora
Dr. Zamora is one of the founders of BioSET and one of the inventors of BioSET’s peptide technology. He continues to direct many of the in vitro and in vivo evaluations of Amplex and BioSET’s peptide technology. He has more than 22 years of industry experience related to the development of biopharmaceuticals, and more recently, medical devices. He is an author on 69 scientific articles and inventor on 24 U.S. patents. He has specialized in pre-clinical product development and evaluation, and prior to joining BioSET, developed peptide- and antibody-based diagnostic pharmaceuticals.
current job
organization founded
Paul Zamora